High-Throughput Screening (HTS)

The HTS Unit at BCDD provides comprehensive capabilities for the rapid and automated screening of large compound libraries against diverse biological targets.

The unit specializes in the development, optimization, and miniaturization of robust in vitro assays for both phenotypic and target-based platforms.

Equipped with high-performance instrumentation for liquid handling, high-content imaging, and plate reading, the facility supports early-stage drug discovery and hit identification. The team collaborates closely with researchers to design tailored screening strategies that align with specific project goals.